Sara Martínez

430 total citations
11 papers, 64 citations indexed

About

Sara Martínez is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Sara Martínez has authored 11 papers receiving a total of 64 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Sara Martínez's work include Cancer therapeutics and mechanisms (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Sara Martínez is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Sara Martínez collaborates with scholars based in United States, Spain and France. Sara Martínez's co-authors include Philip L. Lorenzi, Iqbal Mahmud, Weston W. Porter, Katherine E. Pendleton, James P. Barrish, Tao Wang, Bora Lim, Matthew D. Meyer, Gloria V. Echeverria and Lin Tan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Sara Martínez

8 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Martínez United States 5 41 26 14 5 5 11 64
Luay Aswad Sweden 4 82 2.0× 43 1.7× 21 1.5× 7 1.4× 6 1.2× 7 113
Nicole Teichmann Germany 3 33 0.8× 10 0.4× 24 1.7× 4 0.8× 14 2.8× 3 67
Rongqin Zhang China 5 43 1.0× 16 0.6× 6 0.4× 7 1.4× 3 0.6× 8 87
Alexandra Ambrico United States 2 80 2.0× 44 1.7× 13 0.9× 12 2.4× 2 0.4× 2 100
Galabina Yordanova United Kingdom 2 29 0.7× 26 1.0× 24 1.7× 18 3.6× 6 1.2× 4 69
Nicolas Wyhs United States 5 60 1.5× 23 0.9× 22 1.6× 14 2.8× 2 0.4× 14 90
Anthony W. Martinelli United Kingdom 4 38 0.9× 21 0.8× 5 0.4× 5 1.0× 8 74
Ian Waters United States 5 23 0.6× 16 0.6× 16 1.1× 8 1.6× 8 60
Csaba Halmagyi United Kingdom 2 27 0.7× 27 1.0× 26 1.9× 18 3.6× 4 0.8× 2 68
Abayomi Mosaku South Africa 2 24 0.6× 25 1.0× 25 1.8× 19 3.8× 4 0.8× 3 63

Countries citing papers authored by Sara Martínez

Since Specialization
Citations

This map shows the geographic impact of Sara Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Martínez more than expected).

Fields of papers citing papers by Sara Martínez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Martínez. The network helps show where Sara Martínez may publish in the future.

Co-authorship network of co-authors of Sara Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Martínez. A scholar is included among the top collaborators of Sara Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Martínez. Sara Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mahmud, Iqbal, Bo Wei, Lucas Veillon, et al.. (2025). Ion suppression correction and normalization for non-targeted metabolomics. Nature Communications. 16(1). 1347–1347. 5 indexed citations
2.
Falcón, Alejandro, Santiago Ponce, Gregory M. Coté, et al.. (2025). Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors. Investigational New Drugs. 43(4). 955–967.
3.
Liopo, Anton V., Philip L. Lorenzi, Lin Tan, et al.. (2024). Pleozymes: Pleiotropic Oxidized Carbon Nanozymes Enhance Cellular Metabolic Flexibility. Nanomaterials. 14(24). 2017–2017.
4.
Ghalib, Mohammad H., Mariano Provencio, Maria J. de Miguel, et al.. (2024). A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors. Investigational New Drugs. 42(5). 481–491.
5.
Paz‐Ares, Luis, Alejandro Falcón, Alejandro Navarro, et al.. (2024). Efficacy and safety of lurbinectedin (LUR) with irinotecan (IRI) in patients (Pts) with relapsed small cell lung cancer (SCLC): Results from a phase 2 expansion cohort.. Journal of Clinical Oncology. 42(16_suppl). 8094–8094. 1 indexed citations
6.
Soma, Shivatheja, Lin Tan, Sara Martínez, et al.. (2023). Noncanonical role of singleminded-2s in mitochondrial respiratory chain formation in breast cancer. Experimental & Molecular Medicine. 55(5). 1046–1063. 3 indexed citations
7.
Baek, Mokryun L., Katherine E. Pendleton, Lin Tan, et al.. (2023). Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment. Oncogene. 42(14). 1117–1131. 34 indexed citations
8.
Tan, Lin, Sara Martínez, Philip L. Lorenzi, & Anja Karlstaedt. (2023). Quantitative Analysis of Acetyl-CoA, Malonyl-CoA, and Succinyl-CoA in Myocytes. Journal of the American Society for Mass Spectrometry. 34(11). 2567–2574. 6 indexed citations
9.
Mateos, María‐Victoria, Felipe Prósper, Jesús Martín, et al.. (2022). Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Cancer Medicine. 12(4). 3999–4009. 5 indexed citations
10.
Benton, Christopher B., Naval Daver, Farhad Ravandi, et al.. (2017). Phase I study of lurbinectedin (PM11083) in patients with advanced AML and MDS.. Journal of Clinical Oncology. 35(15_suppl). e18521–e18521. 3 indexed citations
11.
Ocio, Enrique M., María‐Victoria Mateos, Felipe Prósper, et al.. (2016). Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma.. Journal of Clinical Oncology. 34(15_suppl). 8006–8006. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luay Aswad Breakdown of academic impact, for papers by Nicole Teichmann Breakdown of academic impact, for papers by Rongqin Zhang Breakdown of academic impact, for papers by Alexandra Ambrico Breakdown of academic impact, for papers by Galabina Yordanova Breakdown of academic impact, for papers by Nicolas Wyhs Breakdown of academic impact, for papers by Anthony W. Martinelli Breakdown of academic impact, for papers by Ian Waters Breakdown of academic impact, for papers by Csaba Halmagyi Breakdown of academic impact, for papers by Abayomi Mosaku
Rankless by CCL
2026